Profile
ALUR ABT BSX-PA BSX SYK MDT
Company Name Allurion Technologies Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $13.54M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.13K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Dr. Shantanu K. Gaur M.D. Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
ALUR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
ALUR ABT BSX-PA BSX SYK MDT
Last Close $2.4 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $8.87 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.28 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -72.94 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 757.14 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
ALUR ABT BSX-PA BSX SYK MDT
1 Month Return -27.27 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return -72.38 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return 215.75 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return 179.2 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return 458.14 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return 25 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALUR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -69.23 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Profitability
ALUR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 66.45 % 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -79.69 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM 37.55 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM -358.37 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 102.82 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 50.87 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM -155.69 % 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -111.54 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM 4.5 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 1.64 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM 3.17 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM 706.02 % 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM 97.86 % 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -16.34 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -16.57 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 594.03 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM -131.73 % 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.44 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -111.54 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -0.32 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -0.14 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -0.14 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Revenue $0.03B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0.02B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 66.97% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.02B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -0.01 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
ALUR ABT BSX-PA BSX SYK MDT
Long Term Debt $0.04B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0.11B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $-0.08B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0.04B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.04B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
AMIX Autonomix Medical, Inc. Common Stock 2.08
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 0.8905
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.98
AXDX Accelerate Diagnostics, Inc. 0.5775
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
ETFs With Exposure to ALUR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
VXF Vanguard Extended Market Index Fund 0 170
IWC iShares Micro-Cap ETF 0.00044 110.33
JSML Janus Henderson Small Cap Growth Alpha ETF 0.01 58.91
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.34
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.33
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.33
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock